480 related articles for article (PubMed ID: 12666586)
1. [Persistence of immunity after hepatitis B vaccination].
Madaliński K
Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
[TBL] [Abstract][Full Text] [Related]
2. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
[TBL] [Abstract][Full Text] [Related]
3. Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B vaccine.
Madaliński K; Sylvan SP; Hellstrom U; Mikołajewicz J; Dzierzanowska-Fangrat K
Med Sci Monit; 2004 Jan; 10(1):PI10-7. PubMed ID: 14704645
[TBL] [Abstract][Full Text] [Related]
4. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
5. [Vaccination against hepatitis B].
Madaliński K; Mikołajewicz J; Michalska Z
Przegl Epidemiol; 1996; 50(1-2):3-14. PubMed ID: 8711156
[TBL] [Abstract][Full Text] [Related]
6. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.
Rendi-Wagner P; Shouval D; Genton B; Lurie Y; Rümke H; Boland G; Cerny A; Heim M; Bach D; Schroeder M; Kollaritsch H
Vaccine; 2006 Apr; 24(15):2781-9. PubMed ID: 16455169
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
[TBL] [Abstract][Full Text] [Related]
10. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
11. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
14. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
Romanò L; Biffi R; Bianchi S; Zanetti A
Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
[No Abstract] [Full Text] [Related]
15. [Results of active preventive vaccination against hepatitis B with a German vaccine].
Henning H; Laufs R; Kätzner K; Bredehorst R
Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
[TBL] [Abstract][Full Text] [Related]
16. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
[TBL] [Abstract][Full Text] [Related]
17. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
18. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
[TBL] [Abstract][Full Text] [Related]
19. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
Kafatos G; Anastassopoulou C; Nardone A; Andrews N; Barbara C; Boot HJ; Butur D; Davidkin I; Gelb D; Griskevicius A; Hesketh L; Icardi G; Jones L; Kra-Oz Z; Miller E; Mossong J; Nemecek V; de Ory F; Sobotová Z; Thierfelder W; Van Damme P; Hatzakis A
J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
